{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:25:35Z","timestamp":1769970335182,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.vhri.2023.11.010","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T23:45:13Z","timestamp":1705621513000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Cost-Effectiveness Analysis Comparing QuantiFERON-TB Gold Plus Test and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Immunocompetent Subjects in Colombia"],"prefix":"10.1016","volume":"41","author":[{"given":"Cristian E.","family":"Navarro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E.","family":"Betancur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vhri.2023.11.010_bib1","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"Mack","year":"2009","journal-title":"Eur Respir J"},{"issue":"22","key":"10.1016\/j.vhri.2023.11.010_bib2","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.vhri.2023.11.010_bib3","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.vhri.2023.11.010_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jmii.2013.07.008","article-title":"Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country","volume":"48","author":"Hung","year":"2015","journal-title":"J\u00a0Microbiol Immunol Infect"},{"issue":"6","key":"10.1016\/j.vhri.2023.11.010_bib5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/occmed\/kqw035","article-title":"Tuberculin and QuantiFERON-TB-Gold tests for latent tuberculosis: a meta-analysis","volume":"66","author":"Doosti-Irani","year":"2016","journal-title":"Occup Med (Lond)"},{"issue":"5","key":"10.1016\/j.vhri.2023.11.010_bib6","first-page":"445","article-title":"Concordance between the test of the tuberculin and interferon gamma Release Assay-IGRA in patients with immune-mediated inflammatory diseases","volume":"32","author":"P\u00e9rez Catal\u00e1n","year":"2019","journal-title":"Rev Esp Quimioter"},{"issue":"2","key":"10.1016\/j.vhri.2023.11.010_bib11","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.vhri.2023.11.010_bib12","first-page":"348","article-title":"Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection","volume":"56","author":"Harada","year":"2008","journal-title":"J\u00a0Infectol"},{"issue":"9","key":"10.1016\/j.vhri.2023.11.010_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JCM.01950-19","article-title":"Fourth-generation QuantiFERON-TB Gold Plus: what is the evidence?","volume":"58","author":"Shafeque","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vhri.2023.11.010_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.15381\/anales.v78i1.13019","article-title":"Costos de bolsillo de pacientes con diagn\u00f3stico de tuberculosis en Colombia","volume":"78","author":"Mart\u00ednez-S\u00e1nchez","year":"2017","journal-title":"An la Fac Med"},{"issue":"4","key":"10.1016\/j.vhri.2023.11.010_bib16","first-page":"129","article-title":"Costo-efectividad de tres pruebas diagn\u00f3sticas de tuberculosis pulmonar en dos ciudades de Colombia, 2015","volume":"39","author":"\u00c1lvarez Pe\u00f1aranda","year":"2019","journal-title":"Enferm Infecc Microbiol"},{"key":"10.1016\/j.vhri.2023.11.010_bib17","author":"Moreno Viscaya"},{"key":"10.1016\/j.vhri.2023.11.010_bib18","author":"Faria"},{"issue":"9","key":"10.1016\/j.vhri.2023.11.010_bib19","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.2016.10357","article-title":"Primary care screening and treatment for latent tuberculosis infection in adults","volume":"316","author":"Kahwati","year":"2016","journal-title":"JAMA"},{"issue":"56","key":"10.1016\/j.vhri.2023.11.010_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22560","article-title":"Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study","volume":"22","author":"Abubakar","year":"2018","journal-title":"Health Technol Assess (Rockv)"},{"issue":"17","key":"10.1016\/j.vhri.2023.11.010_bib24","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.2023.3954","article-title":"Screening for latent tuberculosis infection in adults","volume":"329","author":"Jonas","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vhri.2023.11.010_bib26","first-page":"CD010890","article-title":"Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status","author":"van\u2019t Hoog","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vhri.2023.11.010_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijid.2022.05.029","article-title":"Prevalence trends of latent tuberculosis infection at the global, regional, and country levels from 1990-2019","volume":"122","author":"Ding","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.vhri.2023.11.010_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/08870446.2014.953532","article-title":"Risk of bias in trial-based economic evaluations: identification of sources and bias-reducing strategies","volume":"30","author":"Evers","year":"2015","journal-title":"Psychol Health"},{"issue":"1","key":"10.1016\/j.vhri.2023.11.010_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/EDE.0000000000001418","article-title":"The health and economic benefits of tests that predict future progression to tuberculosis disease","volume":"33","author":"Menzies","year":"2022","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.vhri.2023.11.010_bib34","first-page":"471","article-title":"Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection","volume":"14","author":"Deuffic-Burban","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.vhri.2023.11.010_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03256394","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-\u237a antagonist therapy","volume":"14","author":"Kowada","year":"2010","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"10.1016\/j.vhri.2023.11.010_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03262207","article-title":"Cost effectiveness of interferon-gamma release assay for school-based tuberculosis screening","volume":"16","author":"Kowada","year":"2012","journal-title":"Mol Diagn Ther"},{"issue":"15","key":"10.1016\/j.vhri.2023.11.010_bib37","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1017\/S0950268816001382","article-title":"Cost-effectiveness of interferon-gamma release assays for tuberculosis screening in nursing homes","volume":"144","author":"Kowada","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"12","key":"10.1016\/j.vhri.2023.11.010_bib38","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/jamainternmed.2017.3941","article-title":"Cost-effectiveness of testing and treatment for latent tuberculosis infection in residents born outside the United States with and without medical comorbidities in a simulation model","volume":"177","author":"Tasillo","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.vhri.2023.11.010_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.pulmoe.2021.04.002","article-title":"Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal","volume":"27","author":"Sousa","year":"2021","journal-title":"Pulmonology"},{"issue":"4","key":"10.1016\/j.vhri.2023.11.010_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059546","article-title":"Cost-effectiveness of Quantiferon-TB gold-In-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil","volume":"8","author":"Steffen","year":"2013","journal-title":"PLoS One"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109923001395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109923001395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T14:39:37Z","timestamp":1746110377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109923001395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":27,"alternative-id":["S2212109923001395"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2023.11.010","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness Analysis Comparing QuantiFERON-TB Gold Plus Test and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Immunocompetent Subjects in Colombia","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2023.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}